SALICYLALDEHYDE
Relevant Data
Flavouring Substances Approved by European Union:
General Information
Mainterm | SALICYLALDEHYDE |
Doc Type | ASP |
CAS Reg.No.(or other ID) | 90-02-8 |
Regnum |
172.515 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 6998 |
IUPAC Name | 2-hydroxybenzaldehyde |
InChI | InChI=1S/C7H6O2/c8-5-6-3-1-2-4-7(6)9/h1-5,9H |
InChI Key | SMQUZDBALVYZAC-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C(=C1)C=O)O |
Molecular Formula | C7H6O2 |
Wikipedia | salicylaldehyde |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 122.123 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Complexity | 101.0 |
CACTVS Substructure Key Fingerprint | A A A D c Y B g M A A A A A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A B A A A A G g A A C A A A D A S g m A I w B o A A A g C I A i h S g A A C A A A k I A A I i A E G C M g I J j a C F R K A c U A k 4 B E I m Y e I y C C O A A A A A A A I A A A A A A A A A B A A A A A A A A A A A A = = |
Topological Polar Surface Area | 37.3 |
Monoisotopic Mass | 122.037 |
Exact Mass | 122.037 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 9 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9344 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.9351 |
P-glycoprotein Substrate | Non-substrate | 0.8033 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9458 |
Non-inhibitor | 0.9855 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8808 |
Distribution | ||
Subcellular localization | Mitochondria | 0.9067 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7932 |
CYP450 2D6 Substrate | Non-substrate | 0.8793 |
CYP450 3A4 Substrate | Non-substrate | 0.7523 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6301 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9801 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9552 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6464 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9503 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8545 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9110 |
Non-inhibitor | 0.9747 | |
AMES Toxicity | Non AMES toxic | 0.9133 |
Carcinogens | Non-carcinogens | 0.8136 |
Fish Toxicity | High FHMT | 0.7790 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9663 |
Honey Bee Toxicity | High HBT | 0.7680 |
Biodegradation | Ready biodegradable | 0.8515 |
Acute Oral Toxicity | III | 0.8407 |
Carcinogenicity (Three-class) | Non-required | 0.6665 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.7978 | LogS |
Caco-2 Permeability | 1.9293 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.3639 | LD50, mol/kg |
Fish Toxicity | 0.4870 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.3241 | pIGC50, ug/L |
From admetSAR
Toxicity Profile
Route of Exposure | |
---|---|
Mechanism of Toxicity | |
Metabolism | |
Toxicity Values | |
Lethal Dose | |
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
Minimum Risk Level | |
Health Effects | |
Treatment | |
Reference |
|
From T3DB
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Carbonyl compounds |
Intermediate Tree Nodes | Aldehydes - Aryl-aldehydes - Benzaldehydes |
Direct Parent | Hydroxybenzaldehydes |
Alternative Parents | |
Molecular Framework | Aromatic homomonocyclic compounds |
Substituents | Hydroxybenzaldehyde - Benzoyl - 1-hydroxy-4-unsubstituted benzenoid - 1-hydroxy-2-unsubstituted benzenoid - Phenol - Benzenoid - Monocyclic benzene moiety - Vinylogous acid - Organic oxide - Hydrocarbon derivative - Aromatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as hydroxybenzaldehydes. These are organic aromatic compounds containing a benzene ring carrying an aldehyde group and a hydroxyl group. |
From ClassyFire
Targets
- General Function:
- Zinc ion binding
- Specific Function:
- Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
- Gene Name:
- ESR1
- Uniprot ID:
- P03372
- Molecular Weight:
- 66215.45 Da
References
- Sipes NS, Martin MT, Kothiya P, Reif DM, Judson RS, Richard AM, Houck KA, Dix DJ, Kavlock RJ, Knudsen TB: Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013 Jun 17;26(6):878-95. doi: 10.1021/tx400021f. Epub 2013 May 16. [23611293 ]
From T3DB